Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Volkmann

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
Chest|December 15, 2025
Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical PracticeAnthony J Esposito, Kavitha C Selvan, Carrie Richardson, et al.
Research Square|November 1, 2024
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana Bernstein, Shawn E Cowper, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
Best Practice & Research. Clinical Rheumatology|July 4, 2021
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)Henrik Pettersson, Helene Alexanderson, Janet L Poole, et al.
Journal of Scleroderma and Related Disorders|June 18, 2026
Expert recommendations for the management of refractory gastroesophageal reflux disease in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"Michael Hughes, Anna Lo Cricchio, Maria Cristina De Santis, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2023
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice GuidelineGanesh Raghu, Sydney B Montesi, Richard M Silver, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Respiratory Research|January 9, 2023
Expert consensus on the management of systemic sclerosis-associated interstitial lung diseaseFranck F Rahaghi, Vivien M Hsu, Robert J Kaner, et al.
Frontiers in Pharmacology|October 31, 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung DiseaseLesley Ann Saketkoo, Reuben Escorpizo, Janos Varga, et al.
Rheumatology (Oxford, England)|April 20, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilizationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Chest|December 15, 2025
Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical PracticeAnthony J Esposito, Kavitha C Selvan, Carrie Richardson, et al.
Research Square|November 1, 2024
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana Bernstein, Shawn E Cowper, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
Best Practice & Research. Clinical Rheumatology|July 4, 2021
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)Henrik Pettersson, Helene Alexanderson, Janet L Poole, et al.
Journal of Scleroderma and Related Disorders|June 18, 2026
Expert recommendations for the management of refractory gastroesophageal reflux disease in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"Michael Hughes, Anna Lo Cricchio, Maria Cristina De Santis, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2023
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice GuidelineGanesh Raghu, Sydney B Montesi, Richard M Silver, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Respiratory Research|January 9, 2023
Expert consensus on the management of systemic sclerosis-associated interstitial lung diseaseFranck F Rahaghi, Vivien M Hsu, Robert J Kaner, et al.
Frontiers in Pharmacology|October 31, 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung DiseaseLesley Ann Saketkoo, Reuben Escorpizo, Janos Varga, et al.
Rheumatology (Oxford, England)|April 20, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilizationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Pageof 20